AstraZeneca inks $1.5B insitro deal for AI-enabled target discovery of liver, heart disease drugs - Fierce Biotech

AstraZeneca is paying $1.5 billion for AI-powered drug discovery technology to develop treatments for liver and heart disease. This shows how AI could accelerate medical breakthroughs that might eventually help millions of patients.